Efthymios N. Deliargyris
2020
In 2020, Efthymios N. Deliargyris earned a total compensation of $827.2K as Chief Medical Officer at Cytosorbents.
Compensation breakdown
| Bonus | $101,640 |
|---|---|
| Option Awards | $331,912 |
| Salary | $253,212 |
| Stock Awards | $131,800 |
| Other | $8,654 |
| Total | $827,218 |
Deliargyris received $331.9K in option awards, accounting for 40% of the total pay in 2020.
Deliargyris also received $101.6K in bonus, $253.2K in salary, $131.8K in stock awards and $8.7K in other compensation.
Rankings
In 2020, Efthymios N. Deliargyris' compensation ranked 9,369th out of 13,090 executives tracked by ExecPay. In other words, Deliargyris earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,369 out of 13,090 | 28th |
Division Manufacturing | 4,001 out of 5,624 | 29th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 508 out of 799 | 36th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 314 out of 495 | 37th |
Industry Surgical and Medical Instruments and Apparatus | 203 out of 313 | 35th |
Source: SEC filing on April 22, 2022.
Deliargyris' colleagues
We found three more compensation records of executives who worked with Efthymios N. Deliargyris at Cytosorbents in 2020.